Search results

Sort By:

Limit search:

Inhibition and regression of atherosclerotic lesions.

100%

Oka K., Chan L.

Acta Biochimica Polonica

2005

vol. 52

issue 2

311-319

Atherosclerosis, once believed to be a result of a slow, irreversible process resulting from lipid accumulation in arterial walls, is now recognized as a dynamic process with reversibility. Liver-directed gene therapy for dyslipidemia aims to treat patients who are not responsive to currently available primary and secondary prevention. Moreover, gene therapy strategies have also proved valuable in studying the dynamics of atherosclerotic lesion formation, progression, and remodeling in experimental animals. Recent results on the long-term effect of gene therapy suggest that hepatic expression of therapeutic genes suppresses inflammation and has profound effects on the nature of the atherogenic process.

Targeting site-specific chromosome integration.

81%

Nuno-Gonzalez P., Chao H., Oka K.

Acta Biochimica Polonica

2005

vol. 52

issue 2

285-291

The concept of gene therapy was introduced with great promise and high expectations. However, what appeared simple in theory has not translated into practice. Despite some success in clinical trials, the research community is still facing an old problem: namely, the need for a vector that can deliver a gene to target cells without adverse events while maintaining a long-term therapeutic effect. Some of these challenges are being addressed by the development of hybrid vectors which meld two different viral systems to incorporate efficient gene delivery and large cloning capacity with site-specific integration. The two known systems that integrate genes into specific sites in mammalian genomes are the adeno-associated virus and phage integrases. Recent experiments with hybrid vectors incorporating both of these systems are encouraging. However, extensive research should be directed towards the safety and efficacy of this approach before it will be available for gene therapy.

Refine search results

2 Acta Biochimica Polonica

2 2005

2 Oka K.

1 Chan L.

1 Chao H.

1 Nuno-Gonzalez P.

Search results

Inhibition and regression of atherosclerotic lesions.

Targeting site-specific chromosome integration.